Takatsuki, Japan

Yosuke Ogoshi

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 9.2

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yosuke Ogoshi: Innovator in Pharmaceutical Compounds

Introduction

Yosuke Ogoshi is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds. With a total of 3 patents to his name, Ogoshi continues to push the boundaries of medical science.

Latest Patents

Ogoshi's latest patents include a Tetrahydrobenzofurodiazepinone compound and its pharmaceutical use. This invention provides a compound with Pim-1 inhibitory activity, along with a pharmaceutical composition and its applications. Another significant patent is for a Pyrazole compound, which exhibits SGLT1 inhibitory activity. This compound also includes a pharmaceutically acceptable salt and its corresponding pharmaceutical uses.

Career Highlights

Yosuke Ogoshi is currently employed at Japan Tobacco Inc., where he applies his expertise in pharmaceutical research and development. His work has been instrumental in advancing the understanding and treatment of various medical conditions through innovative compounds.

Collaborations

Ogoshi has collaborated with several talented individuals in his field, including Kazuhito Ueyama and Dai Motoda. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Yosuke Ogoshi stands out as a dedicated inventor in the pharmaceutical industry, with a focus on developing compounds that have significant medical applications. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…